MCF Advisors’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,204
Closed -$44.1K 1409
2026
Q1
$44.1K Hold
1,204
﹤0.01% 630
2025
Q4
$54.9K Hold
1,204
﹤0.01% 490
2025
Q3
$51K Buy
1,204
+28
+2% +$1.05K ﹤0.01% 423
2025
Q2
$36.6K Hold
1,176
﹤0.01% 457
2025
Q1
$28.9K Buy
1,176
+614
+109% +$17.1K ﹤0.01% 482
2024
Q4
$16.1K Buy
562
+139
+33% +$3.86K ﹤0.01% 591
2024
Q3
$11.3K Buy
423
+251
+146% +$6.52K ﹤0.01% 631
2024
Q2
$4.41K Buy
+172
New +$3.85K ﹤0.01% 749
2022
Q4
Sell
-182
Closed -$3K 824
2022
Q3
$3K Buy
+182
New +$3.66K ﹤0.01% 641

Other funds holding AORT

MCF Advisors's AORT Position: Q2 2026 in Review

MCF Advisors sold out of Artivion (AORT) in Q2 2026, closing a stake of 1,204 shares — an estimated $44.1K sold.

MCF Advisors first reported a position in AORT in Q3 2022 and held it in 9 quarters. The position peaked at $54.9K in Q4 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • MCF Advisors reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • MCF Advisors sold 1,204 Artivion shares in Q2 2026, an estimated $44.1K.
  • MCF Advisors first reported a position in Artivion in Q3 2022 and held it in 9 quarters.
  • MCF Advisors's Artivion position peaked at $54.9K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.